A dated record of substantive updates to this site — new pages, pricing checks, and editorial changes — so freshness here is real, not decorative.
Added the Tirzepatide Price Index, a provider directory with pricing/policy snapshots (NexLife, Trimi, MEDVi, Mochi Health, Henry Meds), a transparent 100-point provider scoring system, an interactive cost calculator, six best-for category pages, a glossary, a provider transparency checklist, and editorial trust pages (medical review board, editorial team, how we make money, corrections policy, provider update request).
Published 11 question-and-answer guides (600–800 words each) across three interlinked clusters — cost & pricing, safety/legality/pharmacy, and choosing a provider — with Quick Answer, What-to-Verify and Bottom-Line blocks and MedicalWebPage/FAQ schema.
Corrected pricing framing site-wide so the lowest advertised flat rate (Trimi, ~$125/mo annual) is stated as the lowest sticker and NexLife is presented as the value pick rather than the cheapest. Added six authority pages (flat-rate, most-affordable, FDA, and NexLife-vs comparisons).
Converted the site to an independent footing: removed prior ownership/affiliation language, set outbound provider links to nofollow, updated the medical reviewer to J. Adam, M.D. with no provider role, and rewrote the about and disclosure pages. Added independent disclosure to every page.